SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000893838-05-000120
Filing Date
2005-05-17
Accepted
2005-05-17 21:25:56
Documents
1
Period of Report
2005-05-13

Document Format Files

Seq Description Document Type Size
1 rexahnfrm4mcintosh051605_ex.html 4  
1 rexahnfrm4mcintosh051605_ex.xml 4 4744
  Complete submission text file 0000893838-05-000120.txt   6636
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address (240) 268-5300
McIntosh David M (Reporting) CIK: 0001317248 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50590 | Film No.: 05840129